HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JIUYUAN GENE

5.500

+0.1001.85%

Volume:207.00K

Turnover:1.14M

Market Cap:1.32B

PE:8.34

High:5.525

Open:5.500

Low:5.225

Close:5.400

52wk High:13.051

52wk Low:4.600

Shares:240.00M

HK Float Shares:240.00M

Volume Ratio:22.31

T/O Rate:0.09%

Dividend:0.07

Dividend Rate:1.21%

EPS(LYR):0.659

ROE:8.50%

ROA:4.52%

PB:0.67

PE(LYR):8.34

PS:0.87

Loading ...

Overview Company News Filings

Jiuyuan Gene Completes H-Share Full Circulation, Converts 136.30 Million Unlisted Shares

Bulletin Express

JIUYUAN GENE Completes Full Circulation of H Shares

JIUYUAN GENE (02566) Officially Changes Corporate Name

JIUYUAN GENE Finalises Corporate Rebranding to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

Bulletin Express

Jiuyuan Genetic Biopharm Gets HKEX Nod to Convert, List 136 Million Shares

MT Newswires Live

JIUYUAN GENE Receives Listing Approval for H-Share Full Circulation Reform

Hangzhou Jiuyuan Gene wins HKEX listing approval for 136,302,015 converted H shares

Jiuyuan Gene Updates on Public Float: Currently 22.22%, Full-Circulation Plan Targets 31.13% by Q2 2026

Bulletin Express

JIUYUAN GENE Announces Public Float at 22.22%, Aims to Restore Compliance by Q2 2026

Jiuyuan Genetic Biopharmaceutical Gets China Nod for Weight Management Drug Trial

MT Newswires Live

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtained Clinical Trial Approval in China

THOMSON REUTERS

BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In China

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtains Nmpa Approval to Conduct Clinical Trials in China

THOMSON REUTERS

Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry

Jiuyuan Gene Publishes 2025 Results, Declares RMB0.57 Dividend per 10 Shares and Seeks to Abolish Supervisory Committee

Bulletin Express

Jiuyuan Gene releases AGM agenda outlining 17 resolutions, including profit distribution plan and governance restructuring

Bulletin Express

Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026

Bulletin Express

JIUYUAN GENE to Distribute Final Dividend of RMB 0.57 per 10 Shares on July 30

Hangzhou Jiuyuan Gene Engineering proposes final dividend of RMB 0.57 per 10 shares

Jiuyuan Gene releases 2025 ESG report: 19.67 kt CO₂e emitted, 1,794-strong workforce and tighter 2026 resource-efficiency targets

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/02566/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"02566","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"JIUYUAN GENE","latestPrice":5.5,"timestamp":1789542622989,"preClose":5.4,"halted":0,"volume":207000,"delay":0,"changeRate":0.01851851851851845,"floatShares":240000000,"shares":240000000,"eps":0.6592062247954373,"marketStatus":"Not Yet Opened","change":0.1,"latestTime":"09-16 15:10:22","open":5.5,"high":5.525,"low":5.225,"amount":1138286,"amplitude":0.055556,"askPrice":5.55,"askSize":20000,"bidPrice":5.5,"bidSize":40400,"shortable":0,"etf":0,"ttmEps":0.6692379389332141,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":5.4,"dividendRate":0.012061,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"volumeRatio":22.306034578905322,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","floatShares":240000000,"roa":"4.52%","roe":"8.50%","lyrEps":0.659206,"volumeRatio":22.306034578905322,"shares":240000000,"dividePrice":0.066621,"high":5.525,"amplitude":0.055556,"preClose":5.4,"low":5.225,"week52Low":4.6,"pbRate":"0.67","psRate":"0.87","week52High":13.051,"institutionHeld":0,"latestPrice":5.5,"committee":0.337748,"eps":0.6592062247954373,"divideRate":0.012113,"volume":207000,"delay":0,"ttmEps":0.6692379389332141,"open":5.5,"prevYearClose":7.475,"prevWeekClose":5.4,"prevMonthClose":5.4,"prevQuarterClose":5.9,"fiveDayClose":5.18,"twentyDayClose":5.22,"sixtyDayClose":5.99,"dividendFrequency":"A","dividendGrowthYears":0,"fiveYearAvgDividendRate":0.008171466845277964},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02566\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-06-17","symbol":"02566","amount":0.057,"announcedDate":"2026-03-30","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-06-18","defaultRemindTime":1781659800000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-30","payableDate":"2026-06-18","currency":"CNY","dateTimestamp":1781625600000,"payDate":"2026-07-30"},{"date":"2026-03-30","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-18","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-06-13","symbol":"02566","amount":0.056,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-16","defaultRemindTime":1749778200000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-06-16","currency":"CNY","dateTimestamp":1749744000000,"payDate":"2025-07-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02566\",market:\"HK\",,,undefined,":[{"executeDate":"2025-06-13","recordDate":"2025-06-16","paymentDate":"2025-07-30","value":0.056,"currency":"CNY"},{"executeDate":"2026-06-17","recordDate":"2026-06-18","paymentDate":"2026-07-30","value":0.057,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02566\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02566\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02566","date":"2026-09-15","current":8.218542,"percent":0.059497,"low":7.540023,"twenty":9.870927,"median":12.475201,"eighty":16.567829,"high":28.852596,"avg":13.308321,"sd":4.411795,"marketCap":1299446280},"quantilePoints":[{"date":"2024-12-06","current":14.097915,"twenty":14.208262,"median":14.275695,"eighty":14.595644,"marketCap":1946012484},{"date":"2024-12-13","current":13.217326,"twenty":13.348436,"median":13.95821,"eighty":14.334483,"marketCap":1820859096},{"date":"2024-12-20","current":12.20261,"twenty":12.40882,"median":13.381214,"eighty":14.243818,"marketCap":1673619816},{"date":"2024-12-27","current":12.158366,"twenty":12.254449,"median":13.1954,"eighty":14.180675,"marketCap":1666257852},{"date":"2025-01-03","current":11.126814,"twenty":12.0799,"median":12.46117,"eighty":14.042033,"marketCap":1526380536},{"date":"2025-01-10","current":9.714633,"twenty":11.141125,"median":12.29741,"eighty":13.763077,"marketCap":1327607508},{"date":"2025-01-17","current":9.904165,"twenty":10.518129,"median":12.180488,"eighty":13.509332,"marketCap":1354601376},{"date":"2025-01-24","current":10.07429,"twenty":9.9409,"median":12.04207,"eighty":13.348436,"marketCap":1386503220},{"date":"2025-01-28","current":10.358786,"twenty":9.995541,"median":11.819979,"eighty":13.282881,"marketCap":1433128992},{"date":"2025-02-07","current":11.238302,"twenty":10.0243,"median":11.162591,"eighty":13.191014,"marketCap":1546012440},{"date":"2025-02-14","current":11.154484,"twenty":10.062805,"median":11.126814,"eighty":12.776093,"marketCap":1533742500},{"date":"2025-02-21","current":12.73316,"twenty":10.073062,"median":11.193598,"eighty":12.735779,"marketCap":1757055408},{"date":"2025-02-28","current":11.508443,"twenty":10.189099,"median":11.508443,"eighty":12.653552,"marketCap":1582822260},{"date":"2025-03-07","current":12.084413,"twenty":10.276651,"median":11.554796,"eighty":12.584056,"marketCap":1668711840},{"date":"2025-03-14","current":12.91496,"twenty":10.28916,"median":11.611229,"eighty":12.584056,"marketCap":1784049276},{"date":"2025-03-21","current":12.244709,"twenty":10.311241,"median":11.810026,"eighty":12.735779,"marketCap":1690797732},{"date":"2025-03-28","current":11.696332,"twenty":10.344738,"median":11.831112,"eighty":12.72799,"marketCap":1734969516},{"date":"2025-04-03","current":10.807781,"twenty":10.395616,"median":11.800074,"eighty":12.674918,"marketCap":1600000176},{"date":"2025-04-11","current":9.828764,"twenty":10.27298,"median":11.65378,"eighty":12.589531,"marketCap":1445398932},{"date":"2025-04-17","current":9.988361,"twenty":10.075173,"median":11.569961,"eighty":12.56072,"marketCap":1472392800},{"date":"2025-04-25","current":10.079541,"twenty":10.050182,"median":11.463659,"eighty":12.511173,"marketCap":1487116728},{"date":"2025-05-02","current":10.290636,"twenty":10.067013,"median":11.287756,"eighty":12.494061,"marketCap":1467484824},{"date":"2025-05-09","current":10.406872,"twenty":10.062805,"median":11.203375,"eighty":12.472285,"marketCap":1494478692},{"date":"2025-05-16","current":10.339488,"twenty":10.073062,"median":11.154484,"eighty":12.457737,"marketCap":1496932680},{"date":"2025-05-23","current":10.443848,"twenty":10.076938,"median":11.100884,"eighty":12.429027,"marketCap":1516564584},{"date":"2025-05-30","current":10.499086,"twenty":10.079206,"median":11.063697,"eighty":12.408842,"marketCap":1531288512},{"date":"2025-06-06","current":10.405237,"twenty":10.102813,"median":10.92653,"eighty":12.402573,"marketCap":1521472560},{"date":"2025-06-13","current":16.776007,"twenty":10.127345,"median":11.063697,"eighty":12.429027,"marketCap":2453988000},{"date":"2025-06-20","current":13.783342,"twenty":10.148232,"median":11.100884,"eighty":12.535947,"marketCap":2012270160},{"date":"2025-06-27","current":13.241991,"twenty":10.175286,"median":11.154484,"eighty":12.72799,"marketCap":1938650520},{"date":"2025-07-04","current":14.247042,"twenty":10.191457,"median":11.198369,"eighty":12.80722,"marketCap":2085889800},{"date":"2025-07-11","current":16.12378,"twenty":10.199228,"median":11.287756,"eighty":13.164345,"marketCap":2358282468},{"date":"2025-07-18","current":16.959198,"twenty":10.204599,"median":11.508443,"eighty":13.325525,"marketCap":2478527880},{"date":"2025-07-25","current":16.429296,"twenty":10.22327,"median":11.606189,"eighty":13.872228,"marketCap":2409816216},{"date":"2025-08-01","current":16.329429,"twenty":10.25109,"median":11.703755,"eighty":14.068336,"marketCap":2380368360},{"date":"2025-08-08","current":17.296232,"twenty":10.27298,"median":11.825546,"eighty":14.242565,"marketCap":2527607640},{"date":"2025-08-15","current":25.546022,"twenty":10.28665,"median":12.04207,"eighty":14.454008,"marketCap":3727607772},{"date":"2025-08-22","current":27.152477,"twenty":10.291424,"median":12.068084,"eighty":15.48419,"marketCap":3646626168},{"date":"2025-08-29","current":24.186548,"twenty":10.297713,"median":12.158366,"eighty":16.326447,"marketCap":3263804040},{"date":"2025-09-05","current":26.17651,"twenty":10.31224,"median":12.214209,"eighty":16.547432,"marketCap":3528834744},{"date":"2025-09-12","current":23.22216,"twenty":10.322989,"median":12.270192,"eighty":16.690567,"marketCap":3136196664},{"date":"2025-09-19","current":21.82033,"twenty":10.32445,"median":12.326094,"eighty":16.958366,"marketCap":2944785600},{"date":"2025-09-26","current":20.564467,"twenty":10.331172,"median":12.407292,"eighty":17.223519,"marketCap":2768098464},{"date":"2025-10-03","current":22.006879,"twenty":10.341379,"median":12.455816,"eighty":17.606421,"marketCap":2969325480},{"date":"2025-10-10","current":19.015463,"twenty":10.348945,"median":12.489783,"eighty":18.310381,"marketCap":2561963472},{"date":"2025-10-17","current":16.970486,"twenty":10.358786,"median":12.586793,"eighty":18.134776,"marketCap":2284662828},{"date":"2025-10-24","current":16.253675,"twenty":10.405237,"median":12.724544,"eighty":17.900127,"marketCap":2188957296},{"date":"2025-10-31","current":15.392522,"twenty":10.406545,"median":12.739707,"eighty":17.871014,"marketCap":2076073848},{"date":"2025-11-07","current":13.654382,"twenty":10.406872,"median":12.862233,"eighty":17.830642,"marketCap":1840491000},{"date":"2025-11-14","current":13.652109,"twenty":10.414705,"median":13.150654,"eighty":17.669327,"marketCap":1845398976},{"date":"2025-11-21","current":13.022772,"twenty":10.429703,"median":12.977364,"eighty":17.532486,"marketCap":1759509396},{"date":"2025-11-28","current":14.151953,"twenty":10.441671,"median":13.150654,"eighty":17.476552,"marketCap":1919018616},{"date":"2025-12-05","current":15.0671,"twenty":10.446315,"median":13.212896,"eighty":17.360095,"marketCap":2046625992},{"date":"2025-12-12","current":15.021249,"twenty":10.450076,"median":13.373682,"eighty":17.303573,"marketCap":2044172004},{"date":"2025-12-19","current":13.906512,"twenty":10.4562,"median":13.596735,"eighty":17.18567,"marketCap":1896932724},{"date":"2025-12-24","current":13.468772,"twenty":10.460694,"median":13.541362,"eighty":17.140598,"marketCap":1842944988},{"date":"2026-01-02","current":13.594612,"twenty":10.472165,"median":13.526709,"eighty":17.103787,"marketCap":1867484868},{"date":"2026-01-09","current":14.184539,"twenty":10.508332,"median":13.623361,"eighty":17.043007,"marketCap":1953374448},{"date":"2026-01-16","current":15.82386,"twenty":10.552044,"median":13.654647,"eighty":16.970089,"marketCap":2186209278},{"date":"2026-01-23","current":17.221546,"twenty":10.59039,"median":13.760784,"eighty":17.043007,"marketCap":2377029620},{"date":"2026-01-30","current":18.645413,"twenty":10.66635,"median":13.818506,"eighty":17.208843,"marketCap":2585326030},{"date":"2026-02-06","current":17.570145,"twenty":10.791312,"median":13.890789,"eighty":17.500019,"marketCap":2442411318},{"date":"2026-02-13","current":16.566637,"twenty":10.808038,"median":13.930604,"eighty":17.447639,"marketCap":2316142276},{"date":"2026-02-20","current":15.898541,"twenty":10.808553,"median":13.936612,"eighty":17.405456,"marketCap":2219535716},{"date":"2026-02-27","current":15.400942,"twenty":10.876548,"median":13.991046,"eighty":17.345071,"marketCap":2173647600},{"date":"2026-03-06","current":14.146009,"twenty":10.927529,"median":14.014987,"eighty":17.323365,"marketCap":1980434480},{"date":"2026-03-13","current":13.445786,"twenty":10.970802,"median":13.989227,"eighty":17.304533,"marketCap":1891073412},{"date":"2026-03-20","current":14.324288,"twenty":11.037013,"median":13.985049,"eighty":17.25142,"marketCap":2007001284},{"date":"2026-03-27","current":13.721414,"twenty":11.063706,"median":13.970301,"eighty":17.198531,"marketCap":1917640216},{"date":"2026-04-02","current":10.613398,"twenty":11.02367,"median":13.933608,"eighty":17.173124,"marketCap":1671293488},{"date":"2026-04-10","current":10.730025,"twenty":10.921534,"median":13.908042,"eighty":17.15803,"marketCap":1702690620},{"date":"2026-04-17","current":10.908083,"twenty":10.807781,"median":13.879703,"eighty":17.114449,"marketCap":1731672588},{"date":"2026-04-24","current":10.496724,"twenty":10.72787,"median":13.842971,"eighty":17.099223,"marketCap":1666463160},{"date":"2026-04-30","current":10.935086,"twenty":10.702023,"median":13.783342,"eighty":17.068754,"marketCap":1736502916},{"date":"2026-05-08","current":10.594139,"twenty":10.67921,"median":13.733566,"eighty":16.988616,"marketCap":1688199636},{"date":"2026-05-15","current":10.339602,"twenty":10.612541,"median":13.678484,"eighty":16.968896,"marketCap":1651972176},{"date":"2026-05-22","current":9.81785,"twenty":10.57772,"median":13.654515,"eighty":16.961058,"marketCap":1565026272},{"date":"2026-05-29","current":9.044003,"twenty":10.498141,"median":13.649387,"eighty":16.95795,"marketCap":1446683236},{"date":"2026-06-05","current":8.457984,"twenty":10.457266,"median":13.565546,"eighty":16.950392,"marketCap":1354907004},{"date":"2026-06-12","current":7.84515,"twenty":10.439494,"median":13.517899,"eighty":16.945188,"marketCap":1255885280},{"date":"2026-06-18","current":9.015379,"twenty":10.406872,"median":13.501167,"eighty":16.890943,"marketCap":1446683236},{"date":"2026-06-26","current":8.75713,"twenty":10.374116,"median":13.445786,"eighty":16.79658,"marketCap":1398379956},{"date":"2026-07-03","current":9.944532,"twenty":10.341471,"median":13.381214,"eighty":16.771208,"marketCap":1589177912},{"date":"2026-07-10","current":9.593587,"twenty":10.324058,"median":13.25487,"eighty":16.748323,"marketCap":1531213976},{"date":"2026-07-17","current":9.016752,"twenty":10.293006,"median":13.217326,"eighty":16.724074,"marketCap":1444268072},{"date":"2026-07-24","current":7.64292,"twenty":10.258532,"median":13.162063,"eighty":16.679208,"marketCap":1224488148},{"date":"2026-07-31","current":8.064769,"twenty":10.200205,"median":13.05573,"eighty":16.651478,"marketCap":1294527904},{"date":"2026-08-07","current":7.771324,"twenty":10.158149,"median":12.918657,"eighty":16.626081,"marketCap":1249847370},{"date":"2026-08-14","current":8.113953,"twenty":10.118328,"median":12.875119,"eighty":16.619851,"marketCap":1306603724},{"date":"2026-08-21","current":7.572239,"twenty":10.071221,"median":12.803792,"eighty":16.5966,"marketCap":1231733640},{"date":"2026-08-28","current":7.91275,"twenty":10.004985,"median":12.728852,"eighty":16.594582,"marketCap":1287414370},{"date":"2026-09-04","current":7.761732,"twenty":9.969361,"median":12.60048,"eighty":16.584855,"marketCap":1263350550},{"date":"2026-09-11","current":7.972736,"twenty":9.887871,"median":12.500478,"eighty":16.568623,"marketCap":1299446280},{"date":"2026-09-15","current":7.974034,"twenty":9.870927,"median":12.475201,"eighty":16.567829,"marketCap":1299446280}],"updateTime":1789588349282},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02566\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164972787","title":"Jiuyuan Gene Completes H-Share Full Circulation, Converts 136.30 Million Unlisted Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1164972787","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164972787?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:03","pubTimestamp":1778760194,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) announced the formal completion of its H-share full-circulation plan. On 14 May 2026, 136.30 million previously unlisted domestic...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139281477","title":"JIUYUAN GENE Completes Full Circulation of H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1139281477","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139281477?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:48","pubTimestamp":1778759294,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has announced the successful conversion of 136 million non-tradable shares into H shares, which was completed on May 14, 2026. The converted H shares are scheduled to commence trading on the Stock Exchange of Hong Kong at 9:00 a.m. on May 15, 2026.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144850609","title":"JIUYUAN GENE (02566) Officially Changes Corporate Name","url":"https://stock-news.laohu8.com/highlight/detail?id=1144850609","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144850609?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:24","pubTimestamp":1778505870,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) announced that on April 17, 2025, the company obtained a Certificate of Registration of Change of Name of Registered Non-Hong Kong Company issued by the Registrar of Companies in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK1161","BK4581","XBI","399441","BK4588","02566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158860109","title":"JIUYUAN GENE Finalises Corporate Rebranding to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.","url":"https://stock-news.laohu8.com/highlight/detail?id=1158860109","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158860109?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:22","pubTimestamp":1778505765,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (stock short name: JIUYUAN GENE) has completed its previously announced corporate name change. According to the board announcement dated 11 May...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634768974","title":"Jiuyuan Genetic Biopharm Gets HKEX Nod to Convert, List 136 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2634768974","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634768974?lang=en_us&edition=fundamental","pubTime":"2026-05-11 11:19","pubTimestamp":1778469558,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical  said the Hong Kong bourse approved its application to convert and list 136.3 million unlisted shares in the city, according to a Friday filing.Twelve investors hold the relevant shares and account for 56.44% of the drugmaker's total issued shares.Upon completion of the conversion and listing, the pharma company's issued share capital will comprise 245.3 million H shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348814723.USD","LU1813983027.USD","LU1282649141.HKD","LU0762542818.HKD","SG9999002562.SGD","LU1105468828.SGD","HK0000151867.HKD","LU0417516738.SGD","LU0650527681.SGD","LU0516423174.USD","LU0955669360.SGD","HEXmain","HKXCY","LU0594300179.USD","LU1366334578.USD","IE00BZ08YT58.USD","LU0648948544.HKD","LU0165289439.USD","LU1051768304.USD","LU0594300419.USD","80388","LU0488056044.USD","LU0708995583.HKD","LU0261947096.USD","LU0061477393.USD","LU0210527791.USD","LU1655091459.SGD","LU0540923850.HKD","LU1051769294.HKD","LU0359201885.HKD","BK1161","LU0196878994.USD","LU0348825331.USD","00388","LU0561508036.HKD","LU1481107354.HKD","LU1211504680.USD","LU0886674414.USD","02566","LU0516422440.USD","LU0359201612.USD","LU0607220059.USD","LU0784639295.USD","BK1589","LU1807302812.USD","BK1521","LU0630378692.HKD","LU1831875114.USD","LU0577902611.USD","LU1044874839.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112628862","title":"JIUYUAN GENE Receives Listing Approval for H-Share Full Circulation Reform","url":"https://stock-news.laohu8.com/highlight/detail?id=1112628862","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112628862?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:37","pubTimestamp":1778240247,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has announced that the company applied to the Stock Exchange's listing committee for approval to list and trade 136 million H-shares. These shares were converted from 136 million...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633458049","title":"Hangzhou Jiuyuan Gene wins HKEX listing approval for 136,302,015 converted H shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633458049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633458049?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:29","pubTimestamp":1778239788,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Gene Engineering secured Hong Kong Stock Exchange listing clearance for 136,302,015 H shares to be created via conversion of an equal number of previously unlisted shares under its H-share full circulation plan.Converted shares represent about 56.44% of issued shares excluding treasury stock as of announcement date.Completion would leave all shares as H shares, with issued share capital comprising 245,398,800 H shares.Next steps include completing conversion and trading procedures for converted H shares, with progress updates to follow.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL86HBqV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193270052","title":"Jiuyuan Gene Updates on Public Float: Currently 22.22%, Full-Circulation Plan Targets 31.13% by Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1193270052","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193270052?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:44","pubTimestamp":1778057080,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) reported that its public float remains at approximately 22.22%, below the minimum level required under Rule 19A.28B of the Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166172096","title":"JIUYUAN GENE Announces Public Float at 22.22%, Aims to Restore Compliance by Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1166172096","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166172096?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:36","pubTimestamp":1778056615,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has issued an announcement stating that as of the date of this notice, the company's public float stands at approximately 22.22%. This percentage remains below the minimum...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630588219","title":"Jiuyuan Genetic Biopharmaceutical Gets China Nod for Weight Management Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630588219","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630588219?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:43","pubTimestamp":1777383784,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical (HKG:2566) obtained clinical trial approval for the JY54 Injection from China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The product is intended to contribute to glycemic control and weight management.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630305436","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtained Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2630305436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630305436?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:20","pubTimestamp":1777375257,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B07O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630237042","title":"BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In China","url":"https://stock-news.laohu8.com/highlight/detail?id=2630237042","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630237042?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:28","pubTimestamp":1777372108,"startTime":"0","endTime":"0","summary":"BRIEF-Hangzhou Jiuyuan Genetic Biopharmaceutical Says JY54 Injection Obtains NMPA Approval To Conduct Clinical Trials In ChinaApril 28  - Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd 2566.HK:JY54 INJECTION OBTAINS NMPA APPROVAL TO CONDUCT CLINICAL TRIALS IN CHINAFurther company coverage: 2566.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B075:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630772703","title":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd - Jy54 Injection Obtains Nmpa Approval to Conduct Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2630772703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630772703?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:18","pubTimestamp":1777371485,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B075:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141827555","title":"Domestic Semaglutide's First Approval Faces Delays as Companies Cite Data Exclusivity Period Following Patent Expiry","url":"https://stock-news.laohu8.com/highlight/detail?id=1141827555","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141827555?lang=en_us&edition=fundamental","pubTime":"2026-04-25 17:34","pubTimestamp":1777109647,"startTime":"0","endTime":"0","summary":"One month after the core compound patent for Novo Nordisk's (NVO.US) blockbuster weight-loss drug semaglutide expired, no domestic version of semaglutide has yet successfully gained approval. Several...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LLY","BK4585","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVOH","BK1161","BK4007","BK4532","000513","BK4588","02566","LU0154236417.USD","NVOX","BK0188","BK0028","BK0239","BK4599","IE00BKVL7J92.USD","BK0187","01513","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132763389","title":"Jiuyuan Gene Publishes 2025 Results, Declares RMB0.57 Dividend per 10 Shares and Seeks to Abolish Supervisory Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1132763389","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132763389?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:46","pubTimestamp":1777034818,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (“Jiuyuan Gene”) has released its 2025 annual report and issued a 171-page AGM circular outlining key financial results, a planned cash dividend,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193748518","title":"Jiuyuan Gene releases AGM agenda outlining 17 resolutions, including profit distribution plan and governance restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=1193748518","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193748518?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:42","pubTimestamp":1777034574,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (“Jiuyuan Gene”) has issued the proxy form for its Annual General Meeting scheduled for 14:00 on 15 June 2026 at Conference Room 3, No. 23 Eighth...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123642963","title":"Jiuyuan Gene Declares RMB0.57 Final Dividend per 10 Shares for FY2025; Payment Slated for 30 July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1123642963","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123642963?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:43","pubTimestamp":1776951823,"startTime":"0","endTime":"0","summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (Jiuyuan Gene) has announced a final ordinary cash dividend of RMB0.57 per 10 shares (approximately RMB0.057 per share) for the financial year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132935153","title":"JIUYUAN GENE to Distribute Final Dividend of RMB 0.57 per 10 Shares on July 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1132935153","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132935153?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:36","pubTimestamp":1776951414,"startTime":"0","endTime":"0","summary":"JIUYUAN GENE (02566) has announced that it will distribute a final dividend of RMB 0.57 for every 10 shares on July 30, 2026.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566","BK4588","BK1161","VIG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629118837","title":"Hangzhou Jiuyuan Gene Engineering proposes final dividend of RMB 0.57 per 10 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2629118837","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629118837?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:33","pubTimestamp":1776951187,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Jiuyuan Gene Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL8ZFKbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131767136","title":"Jiuyuan Gene releases 2025 ESG report: 19.67 kt CO₂e emitted, 1,794-strong workforce and tighter 2026 resource-efficiency targets","url":"https://stock-news.laohu8.com/highlight/detail?id=1131767136","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131767136?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:23","pubTimestamp":1776943417,"startTime":"0","endTime":"0","summary":"Hangzhou-based biopharma company Jiuyuan Gene has published its second Environmental, Social and Governance (ESG) report, approved by the board on 30 March 2026. The document details governance...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":76,"code":"91000000","status":"200"}]}}